Literature DB >> 1543649

Glucocorticoids in cancer therapy.

R E Coleman1.   

Abstract

Glucocorticoids are often included with other agents in cancer treatment although the mode of action is not clear. They are useful in the primary combination chemotherapy of both acute and chronic lymphocytic leukaemias, Hodgkin's and non-Hodgkin's lymphomas, multiple myeloma and breast cancer. Other uses for glucocorticoids in cancer patients include an anti-inflammatory action for the oedema of cranial and spinal metastases, a weak antihypercalcaemic effect and the ability to suppress tumour-related fever.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543649     DOI: 10.1007/bf02171708

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  17 in total

Review 1.  Bone growth mechanisms and the effects of cytotoxic drugs.

Authors:  H Robson
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids.

Authors:  Ewelina Kluza; Marieke Heisen; Sophie Schmid; Daisy W J van der Schaft; Raymond M Schiffelers; Gert Storm; Bart M ter Haar Romeny; Gustav J Strijkers; Klaas Nicolay
Journal:  Angiogenesis       Date:  2011-01-12       Impact factor: 9.596

3.  High dose dexamethasone and base of brain irradiation for hormone refractory metastatic carcinoma of the prostate.

Authors:  K Hellmann; R H Phillips; M Goold
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

4.  Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

Authors:  Raymond M Schiffelers; Josbert M Metselaar; Marcel H A M Fens; Adriënne P C A Janssen; Grietje Molema; Gert Storm
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

5.  Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo.

Authors:  Wolfgang E Gallwitz; Theresa A Guise; Gregory R Mundy
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms.

Authors:  I Rogatsky; J M Trowbridge; M J Garabedian
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 7.  Inflammation and Cancer: In Medio Stat Nano.

Authors:  Roberto Molinaro; Claudia Corbo; Megan Livingston; Michael Evangelopoulos; Alessandro Parodi; Christian Boada; Marco Agostini; Ennio Tasciotti
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

8.  Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids.

Authors:  I Rogatsky; A B Hittelman; D Pearce; M J Garabedian
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 9.  The risks and benefits of corticosteroids in advanced cancer.

Authors:  R Twycross
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

10.  Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.

Authors:  Amornrat Juasook; Thidarut Boonmars; Zhiliang Wu; Watcharin Loilome; Kulathida Veteewuthacharn; Nissana Namwat; Pakkayanee Sudsarn; Orasa Wonkchalee; Pranee Sriraj; Ratchadawan Aukkanimart
Journal:  Pathol Oncol Res       Date:  2012-08-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.